Evidence map›Paper›PMID 35570901›Full record

ArticleFrontiers in public health2022

Accelerated Epigenetic Age Among Women with Invasive Cervical Cancer and HIV-Infection in Nigeria.

Jonah Musa, Kyeezu Kim, Yinan Zheng, Yishu Qu, Brian T Joyce, Jun Wang, Drew R Nannini, Demirkan B Gursel, Olugbenga Silas, Fatimah B Abdulkareem and 13 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 4 institutions in 2 countries.

Jonah MusaDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Kyeezu KimDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Yinan ZhengDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Yishu QuDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Brian T JoyceDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Jun WangDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Drew R NanniniDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Demirkan B GurselCenter for Global Oncology, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Olugbenga SilasDepartment of Pathology, University of Jos, Jos, Nigeria.
Fatimah B AbdulkareemDepartment of Pathology, College of Medicine, University of Lagos, Lagos, Nigeria.
Godwin ImadeDepartment of Obstetrics and Gynecology, College of Health Sciences, University of Jos, Jos, Nigeria.
Alani S AkanmuDepartment of Hematology and Blood Transfusion, Lagos University Teaching Hospital and College of Medicine, University of Lagos, Lagos, Nigeria.
Jian-Jun WeiCenter for Global Oncology, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Masha KocherginskyDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Kwang-Youn A KimDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Firas WehbeCenter for Global Oncology, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Chad J AchenbachCenter for Global Oncology, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Rose AnorluDepartment of Obstetrics and Gynecology, College of Medicine, University of Lagos, Lagos, Nigeria.
Melissa A SimonDepartment of Obstetrics and Gynecology, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Atiene SagayDepartment of Obstetrics and Gynecology, College of Health Sciences, University of Jos, Jos, Nigeria.
Folasade T OgunsolaDepartment of Medical Microbiology, College of Medicine, University of Lagos, Lagos, Nigeria.
Robert L MurphyCenter for Global Oncology, Institute for Global Health, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Lifang HouDepartment of Preventive Medicine, Division of Cancer Epidemiology and Prevention, Northwestern University Feinberg School of Medicine, Chicago, IL, United States.
Northwestern University · USUniversity of Jos · NGUniversity of Lagos · NGLagos University Teaching Hospital · NG

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
Pathology and Genomics CoreU54CA221205 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI HOU, LIFANG · 2017 to 2021
$4.2M
Northwestern/Nigeria Research Training Program in HIV and Malignancies (NN-HAM)D43TW009575 · FIC · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Chad J Achenbach, Jonah Musa · 2014 to 2026
$4.1M
Vaginal Microbiome in Cervical Intraepithelial Neoplasia and CancerK43TW011416 · FIC · UNIVERSITY OF JOS · PI MUSA, JONAH · 2019 to 2022
$372k
FIC NIH HHS D43 TW009575FIC NIH HHS K43 TW011416NCATS NIH HHS UL1 TR001422
6 · The paper itself

Abstract

Background: Invasive cervical cancer (ICC) is a serious public health burden in Nigeria, where human immunodeficiency virus (HIV) remains highly prevalent. Previous research suggested that epigenetic age acceleration (EAA) could play a role in detection of HIV-associated ICC. However, little research has been conducted on this topic in Africa where the population is most severely affected by HIV-associated ICC. Here, we investigated the association between ICC and EAA using cervical tissues of ICC-diagnosed Nigerian women living with HIV. Methods: We included 116 cervical tissue samples from three groups of Nigerian women in this study: (1) HIV+/ICC+ ( Results: We found the most striking associations between HIV/ICC status and PhenoAge acceleration (PhenoAA). Among HIV-positive women, PhenoAA was on average 13.4 years higher in women with ICC compared to cancer-free women ( Conclusion: PhenoAA is associated with ICC in HIV-infected women in our study. Our findings suggest that PhenoAA may serve as a potential biomarker for further risk stratification of HIV-associated ICC in Nigeria and similar resource-constrained settings.

Indexed as

HIV InfectionsUterine Cervical NeoplasmsAgingEpigenesis, GeneticFemaleHumansNigeriaDNA methylationepigenetic age accelerationhuman immunodeficiency virusinvasive cervical cancerLMIC

Identifiers

PMID35570901
PMCPMC9099239
OpenAlexW4225131919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.